Renal denervation: What happened, and why?

5Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Despite promising results in initial trials, renal denervation failed to achieve its efficacy end points as a treatment for resistant hypertension in the SYMPLICITY HTN-3 trial, the largest trial of this treatment to date (N Engl J Med 2014; 370:1393-1401). Is renal denervation dead, or will future trials and newer technology revive it?.

Cite

CITATION STYLE

APA

Shishehbor, M. H., Hammad, T. A., & Thomas, G. (2017). Renal denervation: What happened, and why? Cleveland Clinic Journal of Medicine, 84(9), 681–686. https://doi.org/10.3949/ccjm.84a.14129

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free